ACTIVE

Bio Wink

Financial year 2025 · Closed on 30/06/2025

Net result
11,7 k €
-76,0 %over 1 year
Gross margin
22 k €
-62,0 %over 1 year
Equity
38,8 k €
+40,4 %over 1 year

Identity

Source · BCE/KBO

Bio Wink is a Cooperative society incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0736.308.291
Incorporation
11/10/2019
Legal form
Cooperative society
Registered office
Rue du Congrès 35
1000 Bruxelles · BruxellesSee on map
Contributed capital
18 000,00 €
Latest accounts
30/06/2025
Joint committees (1)
  • 207
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin22 k €57,9 k €54,8 k €6,5 k €-8,7 k €
EBITDA20,5 k €57,1 k €-5,6 k €-20,9 k €-8,7 k €
Operating result17,9 k €54 k €-8,7 k €-21,4 k €-8,7 k €
Net result11,7 k €48,6 k €-9,3 k €-21,5 k €-8,7 k €
Balance sheet
Equity38,8 k €27,6 k €-12 k €-2,2 k €-8,2 k €
Total assets106,5 k €222,4 k €113,3 k €138,7 k €2,3 k €
Cash15,9 k €69,8 k €9,2 k €883,7 €
Debts67,7 k €194,8 k €125,3 k €140,9 k €10,5 k €
Other
Workforce1,2 ETP1,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 5 ended

Active mandates

IC PHARMA

Director · since 11 octobre 2019 · 0505.707.124

Represented by Tangie LE GALL

Active
INTERCONCEPT

Director · since 11 octobre 2019 · 0543.451.903

Represented by Jean-Baptiste VAN HAMME

Active
IC PHARMA DISTRIBUTION

Director · 0502.266.889

Represented by Jean-Baptiste VAN HAMME

Active

Ended mandates

IC PHARMA

Director · since 11 octobre 2019 · 0505.707.124

Represented by Tangie Le Gall

Ended
IC PHARMA DISTRIBUTION

Director · since 11 octobre 2019 · 0502.266.889

Represented by Jean-Baptiste Van Hamme

Ended
IC PHARMA DISTRIBUTION

Director · since 11 octobre 2019 · 0502.266.889

Represented by Jean-Baptiste VAN HAMME

Ended
INTERCONCEPT

Director · since 11 octobre 2019 · 0543.451.903

Represented by Jean-Baptiste Van Hamme

Ended

Other companies at this address

Rue du Congrès 35 1000 Bruxelles
CompanyCBE no.
0745.460.341
0686.921.336
ACTUA-TVActive
0859.875.603
0758.476.454
AI TOGETHERActive
0772.557.191
Ai Tory GlobalActive
1029.065.080
0713.441.235
Ambris EuropeActive
0747.663.627
ANGLE AGENCYBankrupt
0736.761.619
ArcoaActive
0787.802.029
1024.326.334
0842.030.769
0448.126.835
0804.166.523
0871.159.473
0880.551.548
0835.029.151
0451.264.388
BelglasActive
0533.973.716
BENCH SYSTEMActive
0500.851.778

Full financial information

Source · NBB
20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202111/10/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/2021
Length of the financial year12 months12 months12 months12 months21 months
Filing date28/01/202624/01/202531/01/202421/02/202322/12/2021
General meeting15/12/202516/12/202418/12/202319/12/202220/12/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202515/12/202528/01/2026FrenchPDF
Abridged model30/06/202416/12/202424/01/2025FrenchPDF
Abridged model30/06/202318/12/202331/01/2024FrenchPDF
Abridged model30/06/202219/12/202221/02/2023FrenchPDF
Abridged model30/06/202120/12/202122/12/2021FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 5 ended

Active mandates

IC PHARMA

Director · since 11 octobre 2019 · 0505.707.124

Represented by Tangie LE GALL

Active
INTERCONCEPT

Director · since 11 octobre 2019 · 0543.451.903

Represented by Jean-Baptiste VAN HAMME

Active
IC PHARMA DISTRIBUTION

Director · 0502.266.889

Represented by Jean-Baptiste VAN HAMME

Active

Ended mandates

IC PHARMA

Director · since 11 octobre 2019 · 0505.707.124

Represented by Tangie Le Gall

Ended
IC PHARMA DISTRIBUTION

Director · since 11 octobre 2019 · 0502.266.889

Represented by Jean-Baptiste Van Hamme

Ended
IC PHARMA DISTRIBUTION

Director · since 11 octobre 2019 · 0502.266.889

Represented by Jean-Baptiste VAN HAMME

Ended
INTERCONCEPT

Director · since 11 octobre 2019 · 0543.451.903

Represented by Jean-Baptiste Van Hamme

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office22/09/2021
    SIEGE SOCIAL
    PDF
  • Other15/10/2019
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202511,7 k €
  2. 2024
    Annual accounts 202448,6 k €
  3. 2023
    Annual accounts 2023-9,3 k €
  4. 2022
    Annual accounts 2022-21,5 k €
  5. 2021
    Annual accounts 2021-8,7 k €
  6. 11/10/2019
    IncorporationCooperative society